Compositions and methods for the induction of retinal...

Details Compositions and methods for the induction of retinal... Compositions and methods for the induction of retinal...

2006-11-28

2006-11-28

Saucier, Sandra E. (Department: 1651)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ether doai

C424S094620, C424S094630, C424S094670

Reexamination Certificate

active

07141610

ABSTRACT:
A method comprising administering by ocular route a dose of a glycol ether effective to induce retinal detachment.

REFERENCES:
patent: 5866120 (1999-02-01), Karageozian et al.
patent: 6060463 (2000-05-01), Freeman
patent: WO 91 16070 (1991-10-01), None
patent: WO 99 21512 (1999-05-01), None
Toews et al., “Turnover of Axonally Transported Phospholipids in Nerve Ending of Retinal Ganglion Cells”, J. Neurochemistry 37(5) : 1316-23 (1981).
Reperant et al., “A Comparative Radioautographic Study of the Bidirectional Axonal and Trascellular Transport of Different Amino Acids and Sugars in the Lamprey Visual System”, Brain Research 348 (2) : 348-54 (1985).

Affiliated with

Also associated with

Rating

Compositions and methods for the induction of retinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the induction of retinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the induction of retinal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3635770